<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04864639</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00103607</org_study_id>
    <secondary_id>5P30DK111022-05</secondary_id>
    <nct_id>NCT04864639</nct_id>
  </id_info>
  <brief_title>A Transition of Care Model From Hospital to Community for Hispanic/Latino Adult Patients With Diabetes.</brief_title>
  <acronym>TOC</acronym>
  <official_title>A Transition of Care Model From Hospital to Community for Hispanic/Latino Adult Patients With Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study was designed to address the existing gap in the transition of care of&#xD;
      Hispanic/Latino Adults with diabetes from hospital to community. The over arching goal of&#xD;
      this study is to develop, test, and determine the feasibility of a transition of care (TOC)&#xD;
      model from the hospital to the community for adult Hispanic/Latino patients with diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study is designed to develop, test, and determine the feasibility of a transition&#xD;
      of care model from hospital to the community for adult Hispanic/Latino patients with&#xD;
      diabetes. The proposed study utilized the Plan-Do-Act-Study (PDSA)as a framework. The PDSA is&#xD;
      an iterative process that allows us to test on a small scale and document unexpected&#xD;
      observations and determine what modifications should be made and prepare for next test. A&#xD;
      culturally centered ToC model will be develop based on the following data: 1) results from&#xD;
      semi-structure interviews from our first cohort of Hispanic/Latino participants with diabetes&#xD;
      recently discharged from the hospital (n=4) and providers from the hospital and community&#xD;
      (n=6); 2) feedback from participants in the community during the Community Consultation&#xD;
      Studio think tank. Once developed, the ToC model will be tested with a total of 16&#xD;
      participants discharged from the hospital to the community. The model will incorporate the&#xD;
      preference and perspective of providers and patients. Participants will complete a set of of&#xD;
      questionnaires (demographic, sociocultural and medical history) prior to discharge and a&#xD;
      follow up telephone call interview 30-days post discharge. A total of 5 participants for the&#xD;
      first set of participants will be interview. These interviews will be analyzed for common&#xD;
      patterns and themes for which the results will inform improvement of the ToC. A second cohort&#xD;
      of participants (n=16) will be enrolled. And complete the same set of questionnaires along&#xD;
      with the 30 day post discharge telephone call. Finally, after implementing and enrolling the&#xD;
      second cohort, as small subset will be interview including providers (n=3) to obtain&#xD;
      additional information that will inform further improvement of the ToC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 4, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emergency department visits within 30 days post discharge</measure>
    <time_frame>30 days post-discharge</time_frame>
    <description>The number of times the participant has revisited the ED after their discharge from the hospital.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Re-admissions to the hospital within 30 days post discharge</measure>
    <time_frame>up to 30 days</time_frame>
    <description>The number of times the participant has be admitted to the hospital after their discharge</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Transition of Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental: 32 participants discharge to a culturally relevant plan All 32 participants will be discharge to a culturally relevant discharge plan</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transition of Care Model</intervention_name>
    <description>Participants with diabetes, Hispanic/Latinos, adults will receive newly developed culturally appropriate discharge instructions.</description>
    <arm_group_label>Transition of Care</arm_group_label>
    <other_name>Patient discharge model</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Patients:&#xD;
&#xD;
               1. At least 18 years of age&#xD;
&#xD;
               2. Diagnosis of Diabetes Mellitus&#xD;
&#xD;
               3. Self-identified Hispanic/Latino&#xD;
&#xD;
               4. Spanish or English speaking&#xD;
&#xD;
               5. Currently hospitalized in the Duke University Health System&#xD;
&#xD;
               6. Able to provide informed consent without a proxy&#xD;
&#xD;
          -  Providers:&#xD;
&#xD;
               1. See patients at Duke Regional Hospital or Duke University Hospital&#xD;
&#xD;
               2. Works in the local clinics proving care for the local Hispanic/Latino patients.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There is no exclusion criteria based on comorbidities.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonor Corsino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leonor Corsino, MD</last_name>
    <phone>(919) 684-4005</phone>
    <email>leonor.corsinonunez@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Iris padilla, PhD</last_name>
    <phone>919-613-9771</phone>
    <email>iris.padilla@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Leonor Corsino, MD</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iris Padilla, PhD, MSN, APRN, FNP-BC, FAANP</last_name>
      <email>iris.padilla@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>August 20, 2021</last_update_submitted>
  <last_update_submitted_qc>August 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Spanish</keyword>
  <keyword>Transition of Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that results reported in manuscript after deidentification (text, tables, figures, appendices)</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Sharing will end 5 years after manuscript publication</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

